In non-small-cell lung cancer cells, inhibition of the CDK9/signal transducer and activator of transcription 3 (STAT3) signaling pathway suppresses the expression of STAT3 target genes, including VEGF, thereby inhibiting tumor growth [46]. This evidence concerns the gene STAT3 and non-small cell lung carcinoma.